Anti-cancer pharmaceutical composition, preparation method thereof, oral liquid and preparation method of oral liquid

A composition and oral liquid technology, applied in the field of rare earth element pharmaceutical composition, can solve problems such as unreported results, achieve the effect of improving immunity, quick effect, and improving the ability of anti-cancer and inhibiting cancer cells

Inactive Publication Date: 2020-06-09
王德林
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] In the medical field of exploring rare earths, many scientific and technical personnel have tried to research and develop, made useful attempts, and published some research results. However, the results that really have a configuration system and are used for actual human treatment have not been reported.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-cancer pharmaceutical composition, preparation method thereof, oral liquid and preparation method of oral liquid
  • Anti-cancer pharmaceutical composition, preparation method thereof, oral liquid and preparation method of oral liquid
  • Anti-cancer pharmaceutical composition, preparation method thereof, oral liquid and preparation method of oral liquid

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0049] A kind of raw material ratio of improving immunity and anticancer pharmaceutical composition is as shown in table 1, and the chemical group C of calcium citrate 6 h 8 o 7 .3 / 2Ga.2H 2 O:

[0050] Table 1

[0051]

[0052]

[0053] The above 1-1, 1-2 and 1-3 are used as the control group, in which lanthanum oxide and cerium oxide are not added at the same time, as the control group. The amount of lanthanum oxide added in 1-4, 1-5, and 1-6 is greater than that of cerium oxide, and the amount of cerium oxide added in 1-7, 1-8, 1-9, 1-10, and 1-11 is greater than that of cerium oxide The amount of lanthanum oxide added.

[0054] Rat liver cancer cells were raised with the pharmaceutical composition in Table 1 for 90 days, one course of treatment every 25 days, with an interval of 5 days, and 6 mg of the pharmaceutical composition corresponding to the above-mentioned group numbers was injected every day during the treatment period, and its performance index after 9...

Embodiment 2

[0064] The raw material ratio of a pharmaceutical composition that improves immunity and fights cancer is shown in Table 3:

[0065] Form 3

[0066] Group No Lanthanum oxide / mg Cerium oxide / mg Praseodymium oxide / mg NdO / mg Citric acid / mg Calcium citrate / mg 2-1 70.0 29.91 0.03 0.06 0 0 2-2 70.0 17.91 0.03 0.06 6 6 2-3 60.0 39.91 0.03 0.06 0 0 2-4 60.0 26.91 0.03 0.06 6.5 6.5 2-5 50.0 49.91 0.03 0.06 0 0 2-6 50.0 36.91 0.03 0.06 7 6 2-7 45.0 54.91 0.03 0.06 0 0 2-8 45.0 41.91 0.03 0.06 8 5 2-9 40.0 59.91 0.03 0.06 0 0 2-10 40.0 46.91 0.03 0.06 8 5

[0067] The difference between 2-1 and 2-2 is enough to add citric acid and calcium citrate. 2-3 and 2-4 are the same analogy. Rat liver cancer cells were raised with the pharmaceutical composition in Table 3 for 90 days, with a course of treatment every 25 days, with an interval of 5 days. During the treatment ...

Embodiment 3

[0073] A kind of raw material proportioning of the medicinal composition of improving immunity and anticancer is shown in Table 5:

[0074] Form 5

[0075] Group No Lanthanum oxide / mg Cerium oxide / mg Praseodymium oxide / mg NdO / mg Citric acid / mg Calcium citrate / mg 3-1 48.0 61.09 0.027 0.063 8 5 3-2 46.5 40.41 0.028 0.062 8 5 3-3 44.5 42.41 0.029 0.061 8 5 3-4 43.0 43.91 0.035 0.055 8 5 3-5 41.5 45.41 0.034 0.056 8 5 3-6 40.0 46.91 0.033 0.057 8 5 3-7 38.5 48.41 0.032 0.058 8 5 3-8 37.8 49.11 0.03 0.06 8 5 3-9 36.2 50.715 0.029 0.056 8 5 3-10 35.0 51.91 0.035 0.055 8 5 3-11 34.5 65.41 0.036 0.054 8 5

[0076] Rat liver cancer cells were raised with the pharmaceutical composition in Table 5 for 90 days, with a course of treatment every 25 days, with an interval of 5 days. During the treatment period, 6 mg of the pharmaceutical composition correspond...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
sedimentation rateaaaaaaaaaa
Login to view more

Abstract

The invention relates to the technical field of rare earth element pharmaceutical compositions, and in particular relates to an immune-enhancing anti-cancer pharmaceutical composition. The compositionincludes the following components: 60-250 parts of lanthanum oxide, 15-300 parts of cerium oxide, 0-10 parts of praseodymium oxide, 0-20 parts of neodymium oxide, 0-110 parts of citric acid, and 0-60parts of calcium citrate. The composition solves the problem that no reasonable rare earth element drug system is used for enhancing immunity and treating cancer in the prior art. According to the composition, the lanthanum oxide and the cerium oxide are compounded to form a rare earth element medicine system, the above rare earth element medicine system can integrate the technologies of activating enzyme activity, enhancing immunity, resisting cancer gene harm, inhibiting cancer cell growth and reproduction, targeting treatment and protecting normal cell vitality, can fight or suppress multiple cancers (such as lung cancer, esophageal cancer, liver cancer and breast cancer) and protect normal cells from being harmed.

Description

technical field [0001] The invention relates to the technical field of rare earth element pharmaceutical compositions, in particular to an anticancer pharmaceutical composition, a preparation method, an oral liquid and a preparation method. Background technique [0002] There are many kinds of tumors and malignant tumors, with different properties and types, different tissues and organs involved, different stages of disease, and different responses to various treatments. Due to the excessive growth and reproduction of cancer cells in the body, normal cells are inhibited, and their living environment undergoes major changes. During the continuous invasion of normal cells by cancer cells, the natural immunity and disease resistance of the human body will be significantly reduced. In addition, once cancer is discovered That is to say, it is already relatively serious, and at the same time of using other treatment methods, the inevitable side effects will accelerate the formatio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K33/244A61K9/08A61P35/00A61P35/04A61P37/04A61P29/00A61K31/194
CPCA61K9/0095A61K31/194A61P29/00A61P35/00A61P35/04A61P37/04A61K33/244A61K2300/00
Inventor 王德林
Owner 王德林
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap